The FDA is offering a research grant aimed to improve manufacturing speed and reliability under its Critical Path Manufacturing Sector Initiative. Publicly available, standardized models for manufacturing scale-up will help small companies get to market faster, the FDA says in a Wednesday Federal Register notice.
Washington Drug Letter